title: Targeting the acute myeloid leukemic stem cell compartment by enhancing tumor cell-based vaccines.
abstract: Harvesting the potential of the immune system in order to eradicate (residual) acute myeloid leukemia (AML) cells is the long pursued goal of immunotherapy in AML. Strategies using apoptotic tumor cell vaccines have been explored for many years, without significant clinical improvements. In recent years insight has been gained into the mechanisms activating and interfering with tumor-directed immunity. With the arrival of novel immune-modulating agents allowing for the interference with regulatory molecules and interaction with immune-propelling mechanisms, new doors are opening for increasing vaccination efficacy. Combined with advances in the design of apoptotic tumor-based vaccines, we are on the verge of creating an effective AML vaccine strategy, offering a much needed novel therapeutic option for this devastating disease.
authors.affiliation: Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands.
authors.forename: Jurjen M
authors.initials: JM
authors.lastname: Ruben
authors.forename: Lindy L
authors.initials: LL
authors.lastname: Visser
authors.forename: Hetty J
authors.initials: HJ
authors.lastname: Bontkes
authors.forename: Theresia M
authors.initials: TM
authors.lastname: Westers
authors.forename: Gert J
authors.initials: GJ
authors.lastname: Ossenkoppele
authors.forename: Tanja D
authors.initials: TD
authors.lastname: de Gruijl
authors.forename: Arjan A
authors.initials: AA
authors.lastname: van de Loosdrecht
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D017209:Apoptosis; D060890:B7-H1 Antigen / Q000276:immunology; D019496:Cancer Vaccines; D003713:Dendritic Cells / Q000276:immunology / Q000637:transplantation*; D005818:Genetic Engineering; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000628:therapy*; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D060890:B7-H1 Antigen; D019496:Cancer Vaccines